DisclosureWe earn commission on partner links; ranking is set by our evidence-based methodology — not advertisers. Read policy

Photo: HealthVetted editorial render
GLP-1 receptor agonist

Photo: HealthVetted editorial render
GLP-1 receptor agonist
| # | Product | Active ingredient | Starting price | FDA status | Score | |
|---|---|---|---|---|---|---|
| 1 | Everlywell | — | $49/mo | service | Top ·7.9 | See offer → |
| 2 | Labcorp OnDemand | — | Best ·$29/mo | service | 7.8 | See offer → |
Everlywell is a digital health company, not a lab or device maker. You order a kit online, self-collect a sample at home (dried blood spot from a finger prick, saliva, urine, swab, or stool depending on the test), and mail it back in a prepaid envelope. A clinician in an independent physician network reviews and approves the lab requisition; the sample is then analyzed at a CLIA-certified laboratory (some also CAP-accredited), and a clinician reviews eligible results before they post to your secure online portal, typically within about 5 to 7 business days of the lab processing the sample. Everlywell states its at-home collection methods are clinically validated against traditional in-clinic methods to help ensure accuracy.
Labcorp OnDemand is a testing service, not a therapy. After you purchase online, an independent provider network issues the required order. You then provide a sample, either at a Labcorp patient service center (blood, urine) or via a mail-in self-collection kit such as the ColoFIT stool test. Labcorp's CLIA-certified, CAP-accredited laboratories run standard clinical assays and post quantitative results to your secure portal.
Everlywell's value depends heavily on the specific test. The company states all at-home sample-collection methods are clinically validated against traditional in-clinic methods, and its dried-blood-spot, saliva, and urine approaches rely on collection methods with established laboratory use; samples are run in CLIA-certified, sometimes CAP-accredited labs. Its COVID-19 home collection kit received an FDA Emergency Use Authorization in May 2020, which Everlywell described as the first EUA of its kind issued to a digital health company rather than a single lab. By contrast, the food-sensitivity (IgG) test has no credible diagnostic support: the American Academy of Allergy, Asthma & Immunology states IgG testing is not recommended for diagnosing food allergy or intolerance, because IgG antibodies likely reflect normal exposure and tolerance to foods, not sensitivity. An allergist quoted by STAT News called IgG tests "completely useless" and warned they "do dramatic harm" by prompting unnecessary food elimination. Independent reviewers note standard biomarker results generally align with conventional lab testing, while finger-prick collection can introduce slightly more variance than a venous draw for some markers.
Because testing is performed in Labcorp's own CAP-accredited, CLIA-certified laboratories using the same automated platforms and assays used in routine clinical care, analytical accuracy is on par with what a physician's order would yield; reviewers consistently rate the lab work itself as gold-standard. The ColoFIT mail-in kit is a fecal immunochemical test that detects occult blood as an early colorectal-cancer signal and is a screening tool, not a diagnostic replacement for colonoscopy.
As a sample-collection service rather than a drug or treatment, Everlywell has no pharmacologic side effects. The main physical risk is from the finger-prick lancet: minor pain, a small bruise, or brief bleeding at the puncture site, and a low risk of infection if hygiene is poor. The more meaningful harms are interpretive: a false-positive or false-negative can cause unnecessary anxiety or false reassurance, and results are wellness information, not a diagnosis. The food-sensitivity (IgG) test carries a documented risk of prompting unwarranted food avoidance and overly restrictive diets, which allergists warn can be harmful. Always confirm and interpret results with a qualified clinician before changing diet, supplements, or medication.
As a lab service there is no drug exposure. Physical risks are limited to routine venipuncture effects (bruising, soreness, rare fainting) for in-center draws and negligible risk for mail-in self-collection. The main non-physical risk is misreading an abnormal result without clinical context, which is why provider review and follow-up with your own doctor matter. Individual results vary.
As of 2026, individual Everlywell tests generally range from about $49 to $299, with specialized add-on screenings priced much higher (the Galleri multi-cancer early-detection test has been listed around $949). An Everlywell+ membership has been offered at about $39/month or $449/year, including one free qualifying test monthly and a 20% discount on additional tests. Out of pocket, expect to pay the full sticker price: Everlywell generally does not bill insurance directly. However, many tests are clinician-authorized and can qualify for HSA/FSA payment or reimbursement using an itemized receipt; confirm with your benefits administrator first, since some plans deny wellness-only tests. Costs can rival or exceed an insured copay for the same test ordered through a doctor.
As of 2026, entry tests start near $49 and the ColoFIT mail-in kit is $89, with an independent-provider physician service fee folded into the listed price. Many tests are FSA/HSA eligible. Note that several headline-low prices apply to in-center draws rather than mail-in kits, so factor in a trip to a Labcorp location. No insurance billing; pay out of pocket.
Best for adults (generally 18+) who want convenient, private screening of common biomarkers, such as cholesterol/lipids, HbA1c, vitamin D, thyroid and other hormones, or STIs, and who are comfortable with a finger prick or self-collected sample. It suits people without easy clinic access or those wanting discreet sexual-health testing. It is not a substitute for medical care: anyone with symptoms, an existing diagnosis, or an emergency should see a clinician. Avoid relying on the IgG food-sensitivity test for medical decisions. People who are needle-averse, pregnant with specific concerns, or who need a definitive diagnosis should consult a doctor and use standard clinician-ordered lab testing.
Available to US adults purchasing their own tests; the independent provider network reviews each order for appropriateness. Some tests have age or location restrictions, and certain conditions (for example active GI bleeding for ColoFIT) make a given test unsuitable. Not a substitute for diagnostic care directed by your own physician.
Labcorp OnDemand: Labcorp OnDemand is the consumer storefront for one of the two giants of US clinical lab testing, so the results carry genuine reference-lab credibility. It shines when you want the exact assay your doctor would order and are fine visiting a Labcorp center; it is less of a pure mail-in-kit play than dedicated DTC brands. Both are strong options — match the pick to your specific needs, budget, and clinician's guidance.
Editorial comparison, not medical advice. Discuss options with a qualified clinician. Individual results vary.